Assessment of Pattern of CD4+ T-Cell Recovery Among Human Immunodeficiency Virus Patients After Initiation of Highly Active Antiretroviral Therapy at Arsi Negelle Health Center, Ethiopia: A Retrospective Cross-Sectional Study.
Sileshi Barasa GelbaSurafel FikaduAlemawi Kindie LegesseHiwot WubetMihret Alemu YesufWondwossen AberaTemesgen Bizuayehu WubePublished in: HIV/AIDS (Auckland, N.Z.) (2020)
From our study, we can conclude that CD4+ T cell count has recovered in most of the study participants after HAART initiation. The immunological non-response rate of study participants was 22.1% after 12 months on HAART and 7.2% at the end of the study.